Download PDF
Thromb Haemost 2013; 109(05): 971-973
DOI: 10.1160/TH12-12-0908
Letters to the Editor
Schattauer GmbH

Transient pseudothrombocytopenia associated with immune heparin-induced thrombocytopenia complicated by pulmonary embolism

Ann B. Zimrin
1   Department of Medicine, University of Maryland Greenebaum Cancer Center, Baltimore, Maryland, USA
,
Theodore E. Warkentin
2   Department of Pathology and Molecular Medicine, and Department of Medicine, Michael G. DeGroote School of Medicine, McMaster University, Hamilton, Ontario, Canada
› Author Affiliations Financial support: This study was supported by the Heart and Stroke Foundation of Ontario(operating grant #T6950 [T.E. Warkentin]).
Further Information

Publication History

Received: 07 December 2013

Accepted after minor revision: 23 January 2013

Publication Date:
22 November 2017 (online)

Also available at
    Permissions and Reprints

 

 

  • References

  • 1 Warkentin TE, Greinacher A, Gruel Y. et al. on behalf of the Scientific, Standardization Committee of the International Society on Thrombosis, Haemostasis Laboratory testing for heparin-induced thrombocytopenia: a conceptual framework and implications for diagnosis. J Thromb Haemost 2011; 09: 2498-2500.
    CrossrefPubMedGoogle Scholar
  • 2 Greinacher A, Farner B, Kroll H. et al. Clinical features of heparin-induced thrombocytopenia including risk factors for thrombosis A retrospective analysis of 408 patients. Thromb Haemost 2005; 94: 132-135.
    Article in Thieme ConnectPubMedGoogle Scholar
  • 3 Bizzaro N. EDTA-dependent pseudothrombocytopenia: A clinical and epidemiological study of 112 cases, with 10-year follow-up. Am J Hematol 1995; 50: 103-109.
    CrossrefPubMedGoogle Scholar
  • 4 Warkentin TE, Kelton JG. Temporal aspects of heparin-induced thrombocytopenia. N Engl J Med 2001; 344: 1286-1292.
    CrossrefPubMedGoogle Scholar
  • 5 Schwarzinger I, Speiser W, Lubenow N. et al. Heparin-platelet factor (PF) 4 antibodies in patients with pseudothrombocytopenia: coincidence or association?. Thromb Haemost 2000; 84: 1123-1124.
    Article in Thieme ConnectPubMedGoogle Scholar
  • 6 Martin-Toutain I, Settegrana C, Ankri A. High levels of heparin-platelet factor 4 antibodies in patients with pseudothrombocytopenia: risk of misdiagnosis. Thromb Haemost 2009; 07: 1416-1418.
    CrossrefPubMedGoogle Scholar
  • 7 Balcik OS, Akdeniz D, Cipil H. et al. Heparin platelet factor 4 antibody positivity in pseudothrombocytopenia. Clin Appl Thromb Hemost 2012; 18: 92-95.
    CrossrefPubMedGoogle Scholar